Diquas diquafosol tetrasodium ophthalmic solution 3% regulatory update

Santen said the Japanese Ministry of Health, Labor and Welfare approved Diquas diquafosol tetrasodium ophthalmic solution 3% to treat dry eye. The company plans to launch the 3% ophthalmic solution formulation of uridine 5'-triphosphate (UTP) natural P2Y2 ligand in Japan by the end of the year. ...